GLP Watchdog

Novera MD vs Vitakey

Neither Novera MD nor Vitakey has an FDA warning letter on record. On compounded tirzepatide injection, Novera MD costs $88 less a year at standing rates: $164.31 a month against $171.67 a month at Vitakey. It is one of two products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Novera MD / Vitakey

Novera MD logo

Novera MD

5.3/10

Vitakey logo

Vitakey

8.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$94.31/moCompounded semaglutide injection
$93/moCompounded semaglutide injection
States
No state list published
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Novera MDFull review
Visit VitakeyFull review

Neither Novera MD nor Vitakey pays us. Links to them earn nothing. Scores: Novera MD 5.3, Vitakey 8.4. How we are paid

What the record shows

  1. 01

    Neither Novera MD nor Vitakey has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded tirzepatide injection, Novera MD costs $88 less a year at standing rates: $164.31 a month against $171.67 a month at Vitakey. It is one of two products the two sell at comparable terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Novera MD

Vitakey

Compounded semaglutide injection

$94.31/mo

$1,132 a year

$93/moLower

$1,116 a year

Compounded tirzepatide injection

$164.31/moLower

$1,972 a year

$171.67/mo

$2,060 a year

Price includes
Not stated
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
Described as month-to-month on the intake's opening screen; plan lengths appear only near the end of the intake
No term beyond the 3-month supply, which is charged in full up front each cycle
Refunds
Not stated in the terms; the intake promises "Guaranteed or it's free" without conditions
Money back for medication still unshipped; nothing back once the pharmacy sends it
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Novera MD: October 8, 2026. Vitakey: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Novera MD

5.3/10
  • $88 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit Novera MD

The case for Vitakey

8.4/10
  • $16 a year less on compounded semaglutide injection
  • Names no compounding pharmacy
Visit Vitakey

Scores

Novera MD 5.3 · Vitakey 8.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

5.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Novera MD vs Vitakey: questions

Neither Novera MD nor Vitakey has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Vitakey, by $16 a year at standing rates. Novera MD: $94.31 a month, about $1,132 a year. Vitakey: $93 a month, about $1,116 a year.
Novera MD states you can cancel at any time. Vitakey states you can cancel at any time; refunds: money back for medication still unshipped; nothing back once the pharmacy sends it.
Neither Novera MD nor Vitakey pays us. Links to them earn nothing. Scores: Novera MD 5.3, Vitakey 8.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register